KBC Group NV Sells 29,838 Shares of HCA Healthcare, Inc. $HCA

KBC Group NV lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 7.8% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 354,583 shares of the company’s stock after selling 29,838 shares during the quarter. KBC Group NV’s holdings in HCA Healthcare were worth $167,803,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of HCA. State Street Corp raised its stake in shares of HCA Healthcare by 1.0% during the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after acquiring an additional 76,039 shares in the last quarter. Capital World Investors increased its holdings in HCA Healthcare by 0.8% during the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after purchasing an additional 40,086 shares during the period. Geode Capital Management LLC lifted its holdings in shares of HCA Healthcare by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after buying an additional 13,565 shares during the period. Norges Bank purchased a new position in shares of HCA Healthcare during the fourth quarter valued at $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after acquiring an additional 245,887 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 0.1%

Shares of HCA stock opened at $371.60 on Monday. The company has a market cap of $82.44 billion, a PE ratio of 12.78, a PEG ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The business’s fifty day simple moving average is $392.25 and its 200-day simple moving average is $456.93.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the firm earned $6.45 earnings per share. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 29.73 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were paid a $0.78 dividend. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Wall Street Analyst Weigh In

Several research firms have recently commented on HCA. Cantor Fitzgerald reduced their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a report on Tuesday, July 7th. Robert W. Baird reduced their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Oppenheimer reduced their price target on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research note on Tuesday, April 28th. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $486.14.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.